Sogipharma SA
Sogipharma reported total assets of €1.43m at the end of the 2025 financial year (annual accounts filed with the NBB on 11 Jun 2026).
The score of Sogipharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets +12 %
Accounts of the company itself (not consolidated).
The full file covers 16 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sogipharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Jun 2026
- Year ended 31 Dec 2024filed on 02 Jun 2025
- Year ended 31 Dec 2023filed on 04 Jun 2024
- Year ended 31 Dec 2022filed on 08 Jun 2023
- Year ended 31 Dec 2021filed on 03 Jun 2022
Sogipharma's financial analysis
- Solvency34.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sogipharma
Sogipharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0440.387.324
- VAT number
- BE0440387324
- Peppol
- Registered · 0208:0440387324 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 06 Mar 1990
- Registered office
- 1300 Wavre
- Latest accounts
- 2025 · filed on 11 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sogipharma (SA) has been based in Wavre since 1990, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 16,514 € and equity of 484,629 €; its revenue is not published. Its solvency stands at 34.0%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sogipharma
Companies in the same business, of comparable size and area, outside its group.
- De la Dreve Retail sale of pharmaceutical products Waterloo · balance sheet €1.40m
- Dynamic Pharma Retail sale of pharmaceutical products Arlon · balance sheet €1.43m
- Pharmacie Jonckheere Retail sale of pharmaceutical products Tubize · balance sheet €1.43m
- Romarix Retail sale of pharmaceutical products Liedekerke · balance sheet €1.43m
- Duopharm Retail sale of pharmaceutical products Lebbeke · balance sheet €1.43m
- Apoteek Piqueur Retail sale of pharmaceutical products Kapellen · balance sheet €1.42m
- Apotheek Mees Sint-Truiden Retail sale of pharmaceutical products Sint-Truiden · balance sheet €1.43m
- Laleman Pharma Retail sale of pharmaceutical products Diksmuide · balance sheet €1.43m
Frequently asked questions about Sogipharma
What is the revenue of Sogipharma?
Sogipharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sogipharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0440387324 for Sogipharma, if the company is VAT-registered. Its company number (CBE) is 0440.387.324.
Where is the registered office of Sogipharma?
According to the CBE register, the registered office of Sogipharma is in 1300 Wavre.
What is the equity of Sogipharma?
At the close of the 2025 financial year, the equity of Sogipharma amounts to 484,629 €, a solvency of 34.0% of total assets.
Who manages Sogipharma?
The register lists 2 active mandates at Sogipharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sogipharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →